Ginkgo Bioworks Hldgs Inc (DNA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 561,572 | 944,073 | 1,315,792 | 1,550,004 | 380,801 |
| Receivables | 22,443 | 17,899 | 82,465 | 136,142 | 21,906 |
| Inventories | N/A | N/A | N/A | 3,362 | 2,736 |
| TOTAL | $602,744 | $1,001,749 | $1,450,079 | $1,723,045 | $426,542 |
| Non-Current Assets | |||||
| PPE Net | 203,720 | 188,193 | 314,773 | 145,770 | 121,435 |
| Investments And Advances | 48,704 | 78,565 | 113,731 | 115,231 | 103,124 |
| Intangibles | 72,510 | 131,979 | 171,251 | 42,954 | 5,151 |
| Other Non-Current Assets | 449,771 | 264,856 | 489,487 | 43,990 | 18,901 |
| TOTAL | $774,705 | $663,593 | $1,089,242 | $347,945 | $248,611 |
| Total Assets | $1,377,449 | $1,665,342 | $2,539,321 | $2,070,990 | $675,153 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 14,169 | 9,323 | 10,451 | 8,189 | 13,893 |
| Accrued Expenses | 65,387 | 110,051 | 114,694 | 93,332 | 30,505 |
| TOTAL | $107,266 | $163,860 | $172,962 | $134,761 | $73,221 |
| Non-Current Liabilities | |||||
| Deferred Revenues | 27,710 | 44,486 | 47,817 | 33,240 | 28,823 |
| Other Non-Current Liabilities | 455,342 | 246,268 | 456,758 | 178,425 | 3,146 |
| TOTAL | $554,125 | $404,330 | $630,082 | $368,850 | $131,880 |
| Total Liabilities | $661,391 | $568,190 | $803,044 | $503,611 | $205,101 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 58,034 | 53,810 | 48,815 | 36,790 | N/A |
| Common Shares | 5 | 5 | 190 | 161 | 129 |
| Retained earnings | -5,837,557 | -5,290,528 | -4,397,659 | -2,297,925 | -467,878 |
| Other shareholders' equity | -1,806 | 1,484 | -2,632 | 60,299 | 8,676 |
| TOTAL | $716,058 | $1,097,152 | $1,736,277 | $1,567,379 | $470,052 |
| Total Liabilities And Equity | $1,377,449 | $1,665,342 | $2,539,321 | $2,070,990 | $675,153 |